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1. Introduction 
A crude preparation from Lactobacillus bul- 
garikus has been shown by one of us to show anti- 
tumour activity [l-4]. We have found this activity to 
be due to glycopeptides present in the preparation. The 
glycopeptides, polymer-homologs of molecular weight 
1000,200O and approx. 10 000 designated as I, II and 
X, are apparently fragments of a peptidoglycan of the 
A4o type. Although adjuvant activity has been report- 
ed for a bacterial peptidoglycan and its fragments 
[S] this is the first time that a specific antitumour 
effect of bacterial cell wall glycopeptides has been 
observed. The highly promising biological properties 
of the glycopeptides I, II and X have served as impe- 
tus for their structural study, the results of which are 
presented in this paper. 
2. Experimental 
Antitumour activity was tested in mice inoculated 
subcutaneously with sarcoma S-180. Eight to ten days 
after inoculation, when the tumours were IO- 12 mm 
in diameter, the animals were given intravenously a 
single dose of 4-6 mg of the substances under investi- 
gation. 
The antitumour preparation from L. bulgaricus 
(strain 52) was obtained by lysozyme and pepsin 
digestion of the bacterial cells according to Ref. [4]. 
L bulgaricus 51 cell walls were prepared by the method 
163, and then digested by lysozyme. The neutral glyco- 
peptides were separated from acidic and basic material 
by successive filtrations through Dowex 50 WX8 
(I-l+-form) and DEAE-cellulose and isolated by chromato- 
graphy on Sephadex G-50 as shown in fig. 1. 
Amino acids and amino sugars were analysed after 
hydrolysis of the glycopeptides in 5.7 N HCl(20 hr at 
11 S’C) and in 4 N HCl(4 hr at lOS”C), respectively, 
correction being made for the degradation of the 
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Fig.l. Chromatography of neutral L. bulgaricus glycopeptides 
(200 mg) in aqueous olution on a Sephadex G-50 column 
(2.5 X 80 cm). Fractions X, I and II weighed 30, 58 and 42 
mg, respectively. The optical density (at 220 nm) is shown 
by a solid line, the amino acid content (measured with Folin’s 
reagent) by a dotted line, the sugar content (determined by 
the anthrone method) by a dashed line. 
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amino sugars under these conditions (approx. 20% for 
the 4 hr period). Volatile acids (acetic and lactic, 
identified as the p-bromophenacyl esters by mass- 
spectrometry) were liberated by heating with 4 N 
HzS04 (3 hr at 1OO’C) and estimated in the distillate 
by titration with 0.01 N NaOH. For the enzymic 
hydrolysis, 1% glycopeptide solutions were incubated 
for 72 hr at 37’C with 0.1% pronase at pH 8.5. N- 
terminal amino acids were determined by the dansyl 
method. Molecular weights were determined in aqueous 
solutions osmometrically and by the sedimentation 
equilibrium method at 70 OOOg. Electrophoresis was 
run at 12 V/cm on FN-2 paper at pH 3.5, 6.5 and 8.6 
‘H- and ’ 3CNMR spectra were measured in DzO at 100 
and 25.16 MHz, respectively, CD-spectra in 0.1 N HCl. 
3. Results and discussion 
As can be seen from fig. 1, the glycopeptide frac- 
tion of the cell wall digest comprised three major sub- 
stances, I II and X. The antitumour effect of these 
substances and of the crude L. bulgaricus preparation 
turned out to be most marked on sarcoma S-180, 
which was therefore used for the tests. Already 4-8 
hr after administration of the preparation the effect 
could be detected as microscopic degenerations in the 
tumour cells. This progressed toprofound necrosis 
within 24-72 hr, no relapses being observed in a one 
year period in 30-40% of the cases; the cured animals 
acquired immunity to replantation of the same 
tumour. 
The three glycopeptides I, II and X are neutral as 
shown by their electrophoretic mmobility and by their 
failure to adsorb onto cation and anion exchangers. 
They all appear to associate in aqueous olution, the 
apparent molecular weight, as measured osmometri- 
tally, varying with concentration (even for the smallest 
glycopeptide I it changed from 1100 to 2000 as the 
concentration was raised from 0.5% to 10%). The 
molecular weights estimated (with an accuracy of 
10%) by sedimentation equilibrium distribution at 
concentrations below 0.1 mg/mI were found to be 
1000, 2000 and 10 000 for glycopeptides I, II and X, 
respectively. 
On acid hydrolysis, glycopeptide I yielded 2 moles 
each of ammonia nd acetic acid, and also muramic, 
aspartic and glutamic acids, glucosamine, alanine and 
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lysinelntheratio1:1:1:1:2:1.Bythesignofthe 
Cotton effect at 210 nm, lysine was proved to have 
the Lconfiguration, whereas aspartic and glutamic 
acids had the Dconfiguration. Alanine was found to 
be optically inactive and therefore its two residues in 
glycopeptide I must have opposite configurations. 
The same amino acids and amino sugars in the 
same proportions were found in glycopeptides II and X. 
The NMR spectra of glycopeptide I showed that 
none of its components had been missed in the acid 
hydrolysis. Thus, the 13CNMR spectrum indicated 
the presence of 10 C=O (180- 185 ppm), 11 CH3 and 
CH2 attached to carbon (20-50 ppm) and 19 CH and 
CH2 attached to oxygen or nitrogen (55- 115 ppm) 
of a total of 40 C-atoms. The ‘HNMR spectrum in 
D?O displayed the signals of 3 (C)CH3 (1.45-l .60 
ppm), 2 (CO)CH3 (2.05-2.15 ppm), 6 (C)CH2 
(2.0-3.4 ppm) and 22 H in the form of CH or CH2 
attached to 0 or N (3.5-5.2 ppm), whereas the spec- 
trum in CF3 CO2 H displayed signals from 61 H of 
which 12 were amide hydrogens resonating at 6.5-7.8 
ppm. 
Acid hydrolysis of the NaBHe-reduced glycopep 
tide I yielded glucosamine and muramitol, muramic 
acid being completely absent from the hydrolysate. 
Hence, in the parent substance the muramic aldehyde 
group is free, whereas glucosamine is glycosylated. 
On partial hydrolysis of I with 0.03 N HCl(12 hr 
at 105’C) two glycopeptides were isolated by paper 
chromatography. One of them consisted of Mur, Ala, 
Glu, Lys, and Asp in a 1:2: 1: 1: 1 ratio, while the other 
contained one mole each of GlcNH? , Mur, Ala, Glu, 
and Lys, the absence of either glucosamine orof a 
second mole of Ala thereby demonstrating their ter- 
minal position in the parent molecule. 
The amino acid sequence of I was elucidated by 
hydrolysis with pronase under forced conditions ince 
the glycopeptide resisted the action of pepsin and 
trypsin. Two ninhydrin negative products were isolated 
from the hydrolysate; namely, the disaccharide 
GlcNAc-MurAc, obtained earlier from the Mycobac- 
terium smegmatis cell walls [7], and a glycopeptide 
containing equimolecular mounts of GlcNHz , Mur, 
Ala, and Glu. In turn the ninhydrin positive products 
revealed the tetrapeptide Ala, Asp, Glu, Lys, the first 
amino acid being N-terminal and of Lconfiguration. 
The following sequence was therefore inferred for 
glycopeptide I: 
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i=D-Asxj 
GlcNAc-+MurAc+L-Ala+D-Glu+L-Lys-+F-AlaX 
The structure of glycopeptide I indicated its origin 
from a peptidoglycan related to the A4o group, a 
similar sequence GlcNAc( 1/3+4)MurAc+L-Ala-D-Glu- 
(&+o)L-Lys(@)D-Asp being encountered in these 
biopolymers [8]. The similarity between the sequences 
is however limited by the presence of a ring in the pep- 
tide moiety of glycopeptide I and by amidation of its 
Dalanine residue and of the exocyclic carboxyl of the 
Daspartic residue, as shown by the neutral properties 
of the molecule and the formation of 2 moles of NH3 
on acid hydrolysis. Consequently, in glycopeptide I 
N-acetyl glucosamine is apparently linked to muramic 
acid by a l/3+4 bond, lysine is acylated at the o-amino 
group by the b-carboxyl of glutamic acid and at the 
e-amino group by the /3-carboxyl of aspartic acid; whit’ 
in turn is ol-amidated: 
GlcNAc( lfl+4)MurAc+LAla+ 
D-G~u(G-ta)LLys(e+$)D-AtpNH, 
4 
DAlaNH* 
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Glycopeptides II and X, like I, yielded glucosamine, 
muramitol, and no muramic acid on treatment with 
NaBH4 followed by acid hydrolysis. Therefore, no 
unbroken oligosaccharide chain is present in these two 
glycopeptides, their GlcNAc-MurAc disaccharide 
residues being interconnected by peptide cross-links. 
As fragments of the A4o type of peptidoglycans these 
compounds obviously consist of repeated peptide 
units linked to each other by the D-isoasparagine 
amino group and the D-alanine carboxyl. Since both 
glycopeptides are neutral, their a-carboxyls of the 
glutamic and aspartic residues and the terminal alanine 
residue are apparently amidated; moreover their pep- 
tide moiety should contain a ring which very likely 
is the same as that in glycopeptide I. Hence, glyco- 
peptides II and X can be ascribed the general formula 
GlcNAc( I/J-rcl)MurAc GlcNAc( lI%+4)MurAc 
+ 
LAla 
& 
1 
D-Glu 
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D-AspNHs(P+e)L-Lys+D-Ala 
where n = 1 or 8-10. 
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